nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP1A2—Dacarbazine—pancreatic cancer	0.115	0.177	CbGbCtD
Ramelteon—CYP2C19—Tamoxifen—pancreatic cancer	0.0994	0.152	CbGbCtD
Ramelteon—CYP1A2—Tamoxifen—pancreatic cancer	0.0917	0.141	CbGbCtD
Ramelteon—CYP1A2—Erlotinib—pancreatic cancer	0.0779	0.12	CbGbCtD
Ramelteon—CYP1A2—Fluorouracil—pancreatic cancer	0.0676	0.104	CbGbCtD
Ramelteon—CYP3A4—Tamoxifen—pancreatic cancer	0.048	0.0737	CbGbCtD
Ramelteon—CYP3A4—Erlotinib—pancreatic cancer	0.0408	0.0627	CbGbCtD
Ramelteon—CYP3A4—Irinotecan—pancreatic cancer	0.0369	0.0566	CbGbCtD
Ramelteon—CYP3A4—Docetaxel—pancreatic cancer	0.027	0.0415	CbGbCtD
Ramelteon—CYP3A4—Sunitinib—pancreatic cancer	0.0269	0.0413	CbGbCtD
Ramelteon—CYP3A4—Doxorubicin—pancreatic cancer	0.0201	0.0309	CbGbCtD
Ramelteon—Influenza—Tamoxifen—pancreatic cancer	0.00186	0.0235	CcSEcCtD
Ramelteon—Depression—Tamoxifen—pancreatic cancer	0.00165	0.0209	CcSEcCtD
Ramelteon—Depression—Erlotinib—pancreatic cancer	0.00163	0.0207	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.00157	0.0198	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00152	0.0193	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.00148	0.0187	CcSEcCtD
Ramelteon—Depression—Sunitinib—pancreatic cancer	0.00141	0.0179	CcSEcCtD
Ramelteon—Influenza—Gemcitabine—pancreatic cancer	0.00128	0.0162	CcSEcCtD
Ramelteon—Dysgeusia—Tamoxifen—pancreatic cancer	0.00127	0.016	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.00122	0.0154	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.00117	0.0148	CcSEcCtD
Ramelteon—Arthralgia—Tamoxifen—pancreatic cancer	0.0011	0.0139	CcSEcCtD
Ramelteon—Myalgia—Tamoxifen—pancreatic cancer	0.0011	0.0139	CcSEcCtD
Ramelteon—Arthralgia—Erlotinib—pancreatic cancer	0.00109	0.0138	CcSEcCtD
Ramelteon—Myalgia—Erlotinib—pancreatic cancer	0.00109	0.0138	CcSEcCtD
Ramelteon—Dysgeusia—Sunitinib—pancreatic cancer	0.00108	0.0137	CcSEcCtD
Ramelteon—Thinking abnormal—Epirubicin—pancreatic cancer	0.00106	0.0135	CcSEcCtD
Ramelteon—Thinking abnormal—Doxorubicin—pancreatic cancer	0.000983	0.0125	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000961	0.0122	CcSEcCtD
Ramelteon—Insomnia—Tamoxifen—pancreatic cancer	0.000954	0.0121	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000951	0.0121	CcSEcCtD
Ramelteon—Insomnia—Erlotinib—pancreatic cancer	0.000944	0.012	CcSEcCtD
Ramelteon—Myalgia—Sunitinib—pancreatic cancer	0.000943	0.0119	CcSEcCtD
Ramelteon—Arthralgia—Sunitinib—pancreatic cancer	0.000943	0.0119	CcSEcCtD
Ramelteon—Fatigue—Tamoxifen—pancreatic cancer	0.00091	0.0115	CcSEcCtD
Ramelteon—Fatigue—Erlotinib—pancreatic cancer	0.0009	0.0114	CcSEcCtD
Ramelteon—Mental disability—Epirubicin—pancreatic cancer	0.000844	0.0107	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000823	0.0104	CcSEcCtD
Ramelteon—Insomnia—Sunitinib—pancreatic cancer	0.000817	0.0104	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—pancreatic cancer	0.000781	0.0099	CcSEcCtD
Ramelteon—Fatigue—Sunitinib—pancreatic cancer	0.000779	0.00987	CcSEcCtD
Ramelteon—Asthenia—Tamoxifen—pancreatic cancer	0.000757	0.00959	CcSEcCtD
Ramelteon—Myalgia—Gemcitabine—pancreatic cancer	0.000757	0.00959	CcSEcCtD
Ramelteon—Arthralgia—Gemcitabine—pancreatic cancer	0.000757	0.00959	CcSEcCtD
Ramelteon—Asthenia—Erlotinib—pancreatic cancer	0.000749	0.00949	CcSEcCtD
Ramelteon—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000745	0.00943	CcSEcCtD
Ramelteon—Myalgia—Fluorouracil—pancreatic cancer	0.000744	0.00942	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00073	0.00925	CcSEcCtD
Ramelteon—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000725	0.00919	CcSEcCtD
Ramelteon—Diarrhoea—Tamoxifen—pancreatic cancer	0.000722	0.00915	CcSEcCtD
Ramelteon—Diarrhoea—Erlotinib—pancreatic cancer	0.000714	0.00905	CcSEcCtD
Ramelteon—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000713	0.00904	CcSEcCtD
Ramelteon—Dizziness—Tamoxifen—pancreatic cancer	0.000698	0.00884	CcSEcCtD
Ramelteon—Dizziness—Erlotinib—pancreatic cancer	0.00069	0.00875	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000675	0.00856	CcSEcCtD
Ramelteon—Insomnia—Irinotecan—pancreatic cancer	0.000673	0.00853	CcSEcCtD
Ramelteon—Somnolence—Irinotecan—pancreatic cancer	0.000662	0.00839	CcSEcCtD
Ramelteon—Headache—Tamoxifen—pancreatic cancer	0.000661	0.00838	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000661	0.00837	CcSEcCtD
Ramelteon—Insomnia—Gemcitabine—pancreatic cancer	0.000656	0.00831	CcSEcCtD
Ramelteon—Headache—Erlotinib—pancreatic cancer	0.000654	0.00829	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00065	0.00823	CcSEcCtD
Ramelteon—Asthenia—Sunitinib—pancreatic cancer	0.000648	0.00822	CcSEcCtD
Ramelteon—Insomnia—Fluorouracil—pancreatic cancer	0.000645	0.00817	CcSEcCtD
Ramelteon—Somnolence—Gemcitabine—pancreatic cancer	0.000645	0.00817	CcSEcCtD
Ramelteon—Fatigue—Irinotecan—pancreatic cancer	0.000642	0.00813	CcSEcCtD
Ramelteon—Somnolence—Fluorouracil—pancreatic cancer	0.000634	0.00803	CcSEcCtD
Ramelteon—Nausea—Tamoxifen—pancreatic cancer	0.000627	0.00794	CcSEcCtD
Ramelteon—Fatigue—Gemcitabine—pancreatic cancer	0.000625	0.00792	CcSEcCtD
Ramelteon—Nausea—Erlotinib—pancreatic cancer	0.00062	0.00786	CcSEcCtD
Ramelteon—Diarrhoea—Sunitinib—pancreatic cancer	0.000618	0.00784	CcSEcCtD
Ramelteon—Dysgeusia—Docetaxel—pancreatic cancer	0.000618	0.00782	CcSEcCtD
Ramelteon—Influenza—Epirubicin—pancreatic cancer	0.00061	0.00773	CcSEcCtD
Ramelteon—Dizziness—Sunitinib—pancreatic cancer	0.000598	0.00757	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000567	0.00719	CcSEcCtD
Ramelteon—Headache—Sunitinib—pancreatic cancer	0.000566	0.00717	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—pancreatic cancer	0.000565	0.00716	CcSEcCtD
Ramelteon—Myalgia—Docetaxel—pancreatic cancer	0.000537	0.0068	CcSEcCtD
Ramelteon—Arthralgia—Docetaxel—pancreatic cancer	0.000537	0.0068	CcSEcCtD
Ramelteon—Nausea—Sunitinib—pancreatic cancer	0.000537	0.0068	CcSEcCtD
Ramelteon—Asthenia—Irinotecan—pancreatic cancer	0.000534	0.00677	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000525	0.00665	CcSEcCtD
Ramelteon—Asthenia—Gemcitabine—pancreatic cancer	0.00052	0.00659	CcSEcCtD
Ramelteon—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000515	0.00652	CcSEcCtD
Ramelteon—Diarrhoea—Irinotecan—pancreatic cancer	0.000509	0.00645	CcSEcCtD
Ramelteon—Diarrhoea—Gemcitabine—pancreatic cancer	0.000496	0.00629	CcSEcCtD
Ramelteon—Dizziness—Irinotecan—pancreatic cancer	0.000492	0.00624	CcSEcCtD
Ramelteon—Diarrhoea—Fluorouracil—pancreatic cancer	0.000488	0.00618	CcSEcCtD
Ramelteon—Dizziness—Fluorouracil—pancreatic cancer	0.000472	0.00597	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000469	0.00594	CcSEcCtD
Ramelteon—Headache—Irinotecan—pancreatic cancer	0.000466	0.00591	CcSEcCtD
Ramelteon—Insomnia—Docetaxel—pancreatic cancer	0.000465	0.0059	CcSEcCtD
Ramelteon—Somnolence—Docetaxel—pancreatic cancer	0.000458	0.0058	CcSEcCtD
Ramelteon—Headache—Gemcitabine—pancreatic cancer	0.000454	0.00576	CcSEcCtD
Ramelteon—Headache—Fluorouracil—pancreatic cancer	0.000447	0.00566	CcSEcCtD
Ramelteon—Fatigue—Docetaxel—pancreatic cancer	0.000444	0.00562	CcSEcCtD
Ramelteon—Nausea—Irinotecan—pancreatic cancer	0.000442	0.0056	CcSEcCtD
Ramelteon—Nausea—Gemcitabine—pancreatic cancer	0.000431	0.00546	CcSEcCtD
Ramelteon—Nausea—Fluorouracil—pancreatic cancer	0.000424	0.00537	CcSEcCtD
Ramelteon—Dysgeusia—Epirubicin—pancreatic cancer	0.000417	0.00528	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—pancreatic cancer	0.000385	0.00488	CcSEcCtD
Ramelteon—Asthenia—Docetaxel—pancreatic cancer	0.000369	0.00468	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000367	0.00136	CbGpPWpGaD
Ramelteon—Arthralgia—Epirubicin—pancreatic cancer	0.000362	0.00459	CcSEcCtD
Ramelteon—Myalgia—Epirubicin—pancreatic cancer	0.000362	0.00459	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—GLI1—pancreatic cancer	0.000358	0.00133	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DTX4—pancreatic cancer	0.000358	0.00133	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GLI1—pancreatic cancer	0.000358	0.00133	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DTX4—pancreatic cancer	0.000358	0.00133	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000356	0.00132	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000356	0.00132	CbGpPWpGaD
Ramelteon—Diarrhoea—Docetaxel—pancreatic cancer	0.000352	0.00446	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—CNR1—pancreatic cancer	0.000351	0.0013	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.000351	0.0013	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NRP1—pancreatic cancer	0.000349	0.00129	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NRP1—pancreatic cancer	0.000349	0.00129	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000349	0.00129	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000349	0.00129	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000347	0.0044	CcSEcCtD
Ramelteon—Dizziness—Docetaxel—pancreatic cancer	0.00034	0.00431	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—GCG—pancreatic cancer	0.000339	0.00126	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—GCG—pancreatic cancer	0.000339	0.00126	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HEY2—pancreatic cancer	0.000336	0.00125	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HEY2—pancreatic cancer	0.000336	0.00125	CbGpPWpGaD
Ramelteon—Myalgia—Doxorubicin—pancreatic cancer	0.000335	0.00425	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—pancreatic cancer	0.000335	0.00425	CcSEcCtD
Ramelteon—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000333	0.00124	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—pancreatic cancer	0.000332	0.00123	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—pancreatic cancer	0.000332	0.00123	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GAST—pancreatic cancer	0.000328	0.00122	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GAST—pancreatic cancer	0.000328	0.00122	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AGTR1—pancreatic cancer	0.000323	0.0012	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000323	0.0012	CbGpPWpGaD
Ramelteon—Headache—Docetaxel—pancreatic cancer	0.000322	0.00409	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000321	0.00407	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000316	0.00401	CcSEcCtD
Ramelteon—Insomnia—Epirubicin—pancreatic cancer	0.000314	0.00398	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—SCT—pancreatic cancer	0.000311	0.00115	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SCT—pancreatic cancer	0.000311	0.00115	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HEY1—pancreatic cancer	0.000311	0.00115	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HEY1—pancreatic cancer	0.000311	0.00115	CbGpPWpGaD
Ramelteon—Somnolence—Epirubicin—pancreatic cancer	0.000309	0.00391	CcSEcCtD
Ramelteon—Nausea—Docetaxel—pancreatic cancer	0.000306	0.00387	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—pancreatic cancer	0.000299	0.00379	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—CCK—pancreatic cancer	0.000297	0.0011	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCK—pancreatic cancer	0.000297	0.0011	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000293	0.00371	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—pancreatic cancer	0.000291	0.00368	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—CNR2—pancreatic cancer	0.000289	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000289	0.00107	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CNR2—pancreatic cancer	0.000289	0.00107	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GLP1R—pancreatic cancer	0.000289	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000289	0.00107	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL8—pancreatic cancer	0.000289	0.00107	CbGpPWpGaD
Ramelteon—Somnolence—Doxorubicin—pancreatic cancer	0.000286	0.00362	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000284	0.00106	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCKAR—pancreatic cancer	0.000284	0.00106	CbGpPWpGaD
Ramelteon—Fatigue—Doxorubicin—pancreatic cancer	0.000277	0.00351	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—JAG2—pancreatic cancer	0.000276	0.00102	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—JAG2—pancreatic cancer	0.000276	0.00102	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MEN1—pancreatic cancer	0.000272	0.00101	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MEN1—pancreatic cancer	0.000272	0.00101	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SHH—pancreatic cancer	0.000259	0.000962	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SHH—pancreatic cancer	0.000259	0.000962	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOTCH4—pancreatic cancer	0.000258	0.000956	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000258	0.000956	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000257	0.000955	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IAPP—pancreatic cancer	0.000256	0.00095	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IAPP—pancreatic cancer	0.000256	0.00095	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.000251	0.00093	CbGpPWpGaD
Ramelteon—Asthenia—Epirubicin—pancreatic cancer	0.000249	0.00316	CcSEcCtD
Ramelteon—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000247	0.000918	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000246	0.000912	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTHLH—pancreatic cancer	0.000246	0.000912	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000246	0.000912	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTCH1—pancreatic cancer	0.000246	0.000912	CbGpPWpGaD
Ramelteon—Diarrhoea—Epirubicin—pancreatic cancer	0.000238	0.00301	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—pancreatic cancer	0.00023	0.00292	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—pancreatic cancer	0.00023	0.00291	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—SST—pancreatic cancer	0.000225	0.000834	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SST—pancreatic cancer	0.000225	0.000834	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000222	0.000823	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000222	0.000823	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—JAG1—pancreatic cancer	0.00022	0.000816	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—JAG1—pancreatic cancer	0.00022	0.000816	CbGpPWpGaD
Ramelteon—Diarrhoea—Doxorubicin—pancreatic cancer	0.00022	0.00278	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—NOTCH3—pancreatic cancer	0.000219	0.000813	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000219	0.000813	CbGpPWpGaD
Ramelteon—Headache—Epirubicin—pancreatic cancer	0.000217	0.00276	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—pancreatic cancer	0.000212	0.00269	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000207	0.00077	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CNR1—pancreatic cancer	0.000207	0.00077	CbGpPWpGaD
Ramelteon—Nausea—Epirubicin—pancreatic cancer	0.000206	0.00261	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	0.000206	0.000764	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000201	0.000747	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000201	0.000747	CbGpPWpGaD
Ramelteon—Headache—Doxorubicin—pancreatic cancer	0.000201	0.00255	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—GCG—pancreatic cancer	0.0002	0.000743	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GCG—pancreatic cancer	0.0002	0.000743	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000195	0.000723	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000195	0.000723	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000193	0.000715	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000191	0.000709	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AGTR1—pancreatic cancer	0.000191	0.000709	CbGpPWpGaD
Ramelteon—Nausea—Doxorubicin—pancreatic cancer	0.000191	0.00242	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—STK11—pancreatic cancer	0.000188	0.000699	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STK11—pancreatic cancer	0.000188	0.000699	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000177	0.000657	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000177	0.000657	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00017	0.00063	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00017	0.00063	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	0.000167	0.000618	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	0.000167	0.000618	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SMAD4—pancreatic cancer	0.000165	0.000612	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000165	0.000612	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000163	0.000606	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000163	0.000606	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	0.000162	0.000602	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HES1—pancreatic cancer	0.000161	0.000598	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HES1—pancreatic cancer	0.000161	0.000598	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	0.00016	0.000595	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000154	0.000572	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000154	0.000572	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	0.000149	0.000554	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	0.000149	0.000553	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000148	0.00055	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL8—pancreatic cancer	0.000148	0.00055	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	0.000146	0.000542	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	0.000146	0.000542	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TERT—pancreatic cancer	0.000141	0.000524	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TERT—pancreatic cancer	0.000141	0.000524	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	0.000139	0.000516	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	0.000139	0.000516	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	0.000138	0.000512	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HIF1A—pancreatic cancer	0.000135	0.000501	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HIF1A—pancreatic cancer	0.000135	0.000501	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TSC2—pancreatic cancer	0.000135	0.0005	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TSC2—pancreatic cancer	0.000135	0.0005	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APOE—pancreatic cancer	0.000132	0.000489	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APOE—pancreatic cancer	0.000132	0.000489	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KDR—pancreatic cancer	0.000129	0.000479	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KDR—pancreatic cancer	0.000129	0.000479	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NFKBIA—pancreatic cancer	0.000123	0.000456	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000123	0.000456	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOTCH1—pancreatic cancer	0.000122	0.000451	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000122	0.000451	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CG—pancreatic cancer	0.000119	0.000441	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000119	0.000441	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—NRAS—pancreatic cancer	0.000119	0.000441	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—NRAS—pancreatic cancer	0.000119	0.000441	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGF—pancreatic cancer	0.000118	0.000436	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGF—pancreatic cancer	0.000118	0.000436	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	0.000117	0.000435	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EGFR—pancreatic cancer	0.000108	0.000402	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EGFR—pancreatic cancer	0.000108	0.000402	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000105	0.000388	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CD—pancreatic cancer	0.000105	0.000388	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000104	0.000384	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000104	0.000384	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—KRAS—pancreatic cancer	0.000102	0.00038	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—KRAS—pancreatic cancer	0.000102	0.00038	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	9.4e-05	0.000349	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	9.4e-05	0.000349	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CB—pancreatic cancer	9.11e-05	0.000338	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CB—pancreatic cancer	9.11e-05	0.000338	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL8—pancreatic cancer	8.75e-05	0.000325	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL8—pancreatic cancer	8.75e-05	0.000325	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HRAS—pancreatic cancer	8.7e-05	0.000323	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HRAS—pancreatic cancer	8.7e-05	0.000323	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AKT1—pancreatic cancer	8.46e-05	0.000314	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AKT1—pancreatic cancer	8.46e-05	0.000314	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CASP3—pancreatic cancer	8.38e-05	0.000311	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CASP3—pancreatic cancer	8.38e-05	0.000311	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PRSS1—pancreatic cancer	8.25e-05	0.000306	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—pancreatic cancer	8.16e-05	0.000303	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—pancreatic cancer	8.16e-05	0.000303	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CTNNB1—pancreatic cancer	8.08e-05	0.0003	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CTNNB1—pancreatic cancer	8.08e-05	0.0003	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MMP9—pancreatic cancer	7.92e-05	0.000294	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MMP9—pancreatic cancer	7.92e-05	0.000294	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTEN—pancreatic cancer	7.87e-05	0.000292	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTEN—pancreatic cancer	7.87e-05	0.000292	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AKT1—pancreatic cancer	7.68e-05	0.000285	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AKT1—pancreatic cancer	7.68e-05	0.000285	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SRC—pancreatic cancer	7.3e-05	0.000271	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SRC—pancreatic cancer	7.3e-05	0.000271	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ARG2—pancreatic cancer	7.15e-05	0.000265	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—pancreatic cancer	7.11e-05	0.000264	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—pancreatic cancer	7.11e-05	0.000264	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STAT3—pancreatic cancer	7.04e-05	0.000261	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STAT3—pancreatic cancer	7.04e-05	0.000261	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NRAS—pancreatic cancer	7.02e-05	0.000261	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NRAS—pancreatic cancer	7.02e-05	0.000261	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—pancreatic cancer	6.54e-05	0.000243	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—pancreatic cancer	6.54e-05	0.000243	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TGFB1—pancreatic cancer	6.53e-05	0.000242	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TGFB1—pancreatic cancer	6.53e-05	0.000242	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PRSS1—pancreatic cancer	6.43e-05	0.000238	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGFR—pancreatic cancer	6.4e-05	0.000238	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGFR—pancreatic cancer	6.4e-05	0.000238	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMP—pancreatic cancer	6.25e-05	0.000232	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—pancreatic cancer	6.05e-05	0.000224	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—pancreatic cancer	6.05e-05	0.000224	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ARG2—pancreatic cancer	5.57e-05	0.000207	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CA—pancreatic cancer	5.55e-05	0.000206	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.55e-05	0.000206	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—pancreatic cancer	5.37e-05	0.000199	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—pancreatic cancer	5.37e-05	0.000199	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.16e-05	0.000191	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRAS—pancreatic cancer	5.14e-05	0.000191	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRAS—pancreatic cancer	5.14e-05	0.000191	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GLP1R—pancreatic cancer	5.04e-05	0.000187	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.96e-05	0.000184	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—DPYD—pancreatic cancer	4.96e-05	0.000184	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMP—pancreatic cancer	4.87e-05	0.000181	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	4.7e-05	0.000175	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.65e-05	0.000173	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—pancreatic cancer	4.54e-05	0.000168	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—pancreatic cancer	4.54e-05	0.000168	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.49e-05	0.000167	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.3e-05	0.00016	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.09e-05	0.000152	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.02e-05	0.000149	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GLP1R—pancreatic cancer	3.93e-05	0.000146	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—DPYD—pancreatic cancer	3.86e-05	0.000143	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.76e-05	0.000139	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	3.66e-05	0.000136	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CD44—pancreatic cancer	3.64e-05	0.000135	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.63e-05	0.000135	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.57e-05	0.000132	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.53e-05	0.000131	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.5e-05	0.00013	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GCG—pancreatic cancer	3.49e-05	0.00013	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—STK11—pancreatic cancer	3.28e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.19e-05	0.000118	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.08e-05	0.000114	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.03e-05	0.000112	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.98e-05	0.000111	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CD44—pancreatic cancer	2.84e-05	0.000105	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.83e-05	0.000105	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.82e-05	0.000105	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.78e-05	0.000103	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.75e-05	0.000102	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GCG—pancreatic cancer	2.72e-05	0.000101	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—STK11—pancreatic cancer	2.56e-05	9.49e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.4e-05	8.91e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APOE—pancreatic cancer	2.3e-05	8.52e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.2e-05	8.17e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CD44—pancreatic cancer	2.19e-05	8.13e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.17e-05	8.07e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GCG—pancreatic cancer	2.1e-05	7.79e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.07e-05	7.69e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPARG—pancreatic cancer	2e-05	7.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—STK11—pancreatic cancer	1.97e-05	7.33e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.82e-05	6.76e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APOE—pancreatic cancer	1.79e-05	6.64e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.7e-05	6.3e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.69e-05	6.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.62e-05	5.99e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.59e-05	5.9e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.57e-05	5.84e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.56e-05	5.79e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.42e-05	5.27e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APOE—pancreatic cancer	1.38e-05	5.13e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.37e-05	5.09e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.25e-05	4.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.24e-05	4.59e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.23e-05	4.55e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.2e-05	4.47e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.1e-05	4.07e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.07e-05	3.97e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	9.68e-06	3.59e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	9.55e-06	3.54e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—pancreatic cancer	9.46e-06	3.51e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.25e-06	3.06e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—pancreatic cancer	7.91e-06	2.94e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	7.54e-06	2.8e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.16e-06	2.29e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.82e-06	2.16e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.76e-06	1.77e-05	CbGpPWpGaD
